Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1999
11/23/1999US5989546 Interleukin-2 stimulated T lymphocyte cell death for the treatment of allergic responses
11/23/1999US5989545 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/23/1999US5989542 Capsular polysaccharides from enterococci
11/23/1999US5989539 Compounds and compositions for delivering active agents
11/23/1999US5989463 Methods for fabricating polymer-based controlled release devices
11/23/1999CA2092420C Vaccine suitable for combatting bordetella pertussis
11/22/1999CA2238660A1 Gene sequences of rubella virus associated with attenuation
11/19/1999CA2237915A1 Osteoporosis treatment
11/18/1999WO1999058726A1 Replication defective hiv vaccine
11/18/1999WO1999058685A2 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
11/18/1999WO1999058684A2 Compounds from moraxella catarrhalis
11/18/1999WO1999058683A2 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
11/18/1999WO1999058682A2 Compounds from moraxella catarrhalis
11/18/1999WO1999058680A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor
11/18/1999WO1999058679A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses
11/18/1999WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
11/18/1999WO1999058660A1 97 human secreted proteins
11/18/1999WO1999058658A2 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999WO1999058647A2 Human deadenylating nuclease, its production and its use
11/18/1999WO1999058645A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
11/18/1999WO1999058639A2 Structural proteins of fish pancreatic disease virus and uses thereof
11/18/1999WO1999058611A2 Process for extracting carotenes from carotene-containing materials
11/18/1999WO1999058573A1 Diagnosis and treatment of hepatic disorders
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058571A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/18/1999WO1999058570A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
11/18/1999WO1999058569A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)
11/18/1999WO1999058564A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999WO1999058563A2 Moraxella catharralis proteins
11/18/1999WO1999058562A2 Novel compounds
11/18/1999WO1999058561A1 Hepatitis c virus mimotopes
11/18/1999WO1999058557A2 Dimers of the hla-b27 heavy chain extracellular domain and uses thereof
11/18/1999WO1999058552A2 Peptides that ellicit t, cellular immunity
11/18/1999WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999WO1999058146A1 ATTENUATED MUTANTS OF SALMONELLA WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN
11/18/1999WO1999058145A2 Immunomodulators for vaccines
11/18/1999WO1999058139A2 Methods for detecting and inhibiting angiogenesis
11/18/1999WO1999058137A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
11/18/1999WO1999058134A1 Methods and compositions for nucleic acid delivery
11/18/1999WO1999058118A2 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
11/18/1999WO1999057981A1 Compositions and methods for active vaccination
11/18/1999WO1999052562A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
11/18/1999WO1999051253A3 Immune response modulation
11/18/1999WO1999050419A3 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999049888A3 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
11/18/1999WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
11/18/1999WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999WO1999047163A3 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999042584A9 Apoptosis inducing molecule ii and methods of use
11/18/1999WO1999042076A9 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/18/1999WO1999037682A3 Antibodies against human il-12
11/18/1999WO1999036094A3 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19821925A1 Bacteriophage expression system for production of composition for induction of tumor specific responses
11/18/1999DE19821009A1 Extraction of carotenes useful as antioxidants and natural colorants in food
11/18/1999CA2685270A1 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999CA2332109A1 97 human secreted proteins
11/18/1999CA2331832A1 E.coli heat-labile enterotoxin subunit b (etxb) as an immunomodulator
11/18/1999CA2331455A1 Novel molecule and diagnosis method
11/18/1999CA2331115A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
11/18/1999CA2330212A1 Compositions and methods for active vaccination
11/18/1999CA2330000A1 Diagnosis and treatment of hepatic disorders
11/18/1999CA2328606A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses
11/18/1999CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis
11/18/1999CA2328492A1 Human deadenylating nuclease, its preparation and use
11/18/1999CA2328429A1 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
11/18/1999CA2328414A1 Methods for detecting and inhibiting angiogenesis
11/18/1999CA2328406A1 Methods for regulating hematopoiesis using cpg-oligonucleotides
11/18/1999CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/18/1999CA2328141A1 Compounds from moraxella catarrhalis
11/18/1999CA2328130A1 Moraxella catarrhalis proteins
11/18/1999CA2328061A1 Novel compounds
11/18/1999CA2327549A1 Peptides that induce t cell responses
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2326581A1 Process for extracting carotenes from carotene-containing materials
11/18/1999CA2288993A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
11/17/1999EP0957162A1 Biological viral material obtained from a multiple sclerosis-associated virus strain infected cell line
11/17/1999EP0956506A1 Treatment and diagnosis of cancer
11/17/1999EP0956360A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
11/17/1999EP0956352A1 A polynucleotide herpes virus vaccine
11/17/1999EP0956349A1 Synthetic hpv16 virus-like particles
11/17/1999EP0956343A1 Recombinant swinepox virus
11/17/1999EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
11/17/1999EP0956304A1 Dendritic cell-specific antibodies
11/17/1999EP0956298A1 Snrnp sm proteins
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
11/17/1999EP0956053A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
11/17/1999EP0956046A2 Cellular vaccines and immunotherapeutics and methods for their preparation
11/17/1999EP0956045A2 Assembly-deficient herpesvirus vaccine
11/17/1999EP0956044A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
11/17/1999EP0956043A1 Strain selection of pneumococcal surface proteins
11/17/1999EP0956042A2 Mycosis vaccines
11/17/1999EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
11/17/1999EP0955948A1 Induction of immunological tolerance
11/17/1999EP0805871B1 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen
1 ... 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 ... 1823